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In the present study, we have used DNA microarray and quanti-
tative real-time PCR analysis to examine the transcriptional
changes that occur in response to cellular depletion of the
yeast acyl-CoA-binding protein, Acb1p. Depletion of Acb1p
resulted in the differential expression of genes encoding proteins
involved in fatty acid and phospholipid synthesis (e.g. FAS
1, FAS2, ACC1, OLE1, INO1 and OPI3), glycolysis and
glycerol metabolism (e.g. GPD1 and TDH1), ion transport
and uptake (e.g. ITR1 and HNM1) and stress response (e.g.
HSP12, DDR2 and CTT1). In the present study, we show
that transcription of the INO1 gene, which encodes inositol-3-
phosphate synthase, cannot be fully repressed by inositol and
choline, and UASINO1 (inositol-sensitive upstream activating se-
quence)-driven transcription is enhanced in Acb1p-depleted cells.
In addition, the reduction in inositol-mediated repression of INO1
transcription observed after depletion of Acb1p appeared to be
independent of the transcriptional repressor, Opi1p. We also
demonstrated that INO1 and OPI3 expression can be normalized
in Acb1p-depleted cells by the addition of high concentrations of
exogenous fatty acids, or by the overexpression of FAS1 or ACC1.
Together, these findings revealed an Acb1p-dependent connection
between fatty acid metabolism and transcriptional regulation of
phospholipid biosynthesis in yeast. Finally, expression of an
Acb1p mutant which is unable to bind acyl-CoA esters could not
normalize the transcriptional changes caused by Acb1p depletion.
This strongly implied that gene expression is modulated either by
the Acb1p–acyl-CoA ester complex directly or by its ability to
donate acyl-CoA esters to utilizing systems.
Key words: acyl-CoA-binding protein (ACBP), fatty acid,
inositol, phospholipid, transcriptional regulation.
INTRODUCTION
In Saccharomyces cerevisiae, fatty acids and fatty acid derivatives
have been suggested to function as regulators of gene expression.
This suggestion is supported by the fact that two oleate-
activated transcription factors, Oaf1p and Pip2p, have been
shown to be essential for fatty-acid-mediated induction of genes
encoding peroxisomal enzymes and proteins [1]. Furthermore,
transcriptional regulation of the yeast 9 desaturase OLE1 by
unsaturated fatty acids involves Spt23p and Mga2p [2].
It has been suggested that the regulatory properties of fatty
acids are mediated through their activation to acyl-CoA esters,
since fatty acids are unable to repress the expression of ACC1 [3]
and OLE1 [4] and induce expression of the peroxisomal enzymes,
acyl-CoA oxidase (POX1) and acyl-CoA synthetase (FAA2) [5]
in S. cerevisiae depleted of the two acyl-CoA synthetases, Faa1p
and Faa4p. However, disruption of both FAA1 and FAA4 affects
fatty acid import, and does not prove that fatty acid activation
is necessarily required for fatty-acid-mediated regulation of gene
expression.
In S. cerevisiae, LCACoA (long-chain acyl-CoA) esters are
either synthesized endogenously by the FAS (fatty acid synthase)
complex or produced from exogenous fatty acids imported by the
fatty acid import machinery. Inside the cell, acyl-CoA esters are
bound to proteins in order to increase their solubility and to protect
them from hydrolysis by thioesterases. A number of intracellular
proteins have been reported to bind LCACoA esters, including
L-FABP (liver fatty-acid-binding protein), SCP (sterol carrier
protein)-2 and ACBP (acyl-CoA-binding protein). L-FABP is
predicted to have a role in LCACoA ester metabolism, and this
is highlighted by the fact that L-FABP-knockout mice display an
altered cytosolic LCACoA ester-binding capacity and ester acyl-
chain distribution [6]. Similarly, SCP-2/SCP-X-knockout mice
demonstrate impaired catabolism of methyl-branched fatty acyl-
CoAs, inefficient transport of phytanoyl-CoA into peroxisomes
and defective thiolytic cleavage of 3-oxopristanoyl-CoA [7].
However, S. cerevisiae does not express fatty-acid-binding protein
[8] or a SCP-2 homologue [9]. Thus S. cerevisiae is suited for
use as a model to study the function of ACBP, since potential
compensatory effects caused by L-FABP and/or SCP-2 can be
avoided.
Yeast ACBP, Acb1p, belongs to a large multi-gene family
encoding a protein approx. 10 kDa in size. Acb1p binds LCACoA
esters in a non-covalent and reversible manner with very high
affinity (Kd of 1–10 nM) and specificity [10]. ACBP has been very
highly conserved throughout evolution, and it has been detected in
all eukaryotic organisms examined so far [11]. The high degree of
sequence and structural conservation of ACBP among eukaryotic
species, and the fact that human ACBP can complement ACBP
function in yeast (S. Feddersen, J. Knudsen and N. J. Færgeman,
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Table 1 Strains used in the present study
Strain Genotype Source or reference
Y700 MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3 [16]
Y700 pGAL-ACB1 MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, pGAL-ACB1::KanMX [16]
Y700 INO1-HA3 MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, INO1-HA3::His3MX Present study
Y700 pGAL-ACB1 INO1-HA3 MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, pGAL-ACB1::KanMX, INO1-HA3::His3MX Present study
Y700 scs2∆ MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, SCS2::TRP1 Present study
Y700 pGAL-ACB1 scs2∆ MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, pGAL-ACB1::KanMX, SCS2::TRP1 Present study
AID MATa/MATα, ade1/ade1 ino1/ino1 S. Henry*
Y700 pld1∆ MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, PLD1::TRP1 Present study
Y700 pGAL-ACB1 pld1∆ MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, pGAL-ACB1::KanMX, PLD1::TRP1 Present study
Y700 hac1∆ MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, HAC1::URA3 Present study
Y700 pGAL-ACB1 hac1∆ MATa, ade2-1 trp1 can1-100 leu2-112 his3-11 his3-15 ura3, pGAL-ACB1::KanMX, HAC1::URA3 Present study
* AID was a gift from Professor Susan Henry, Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, U.S.A. [22]
unpublished work), suggest that its function is associated with
one or more basal cellular function(s) common to all cells [11].
In vitro experiments have shown that ACBP can attenuate the
inhibitory effect of LCACoA esters on acetyl-CoA carboxylase
and the mitochondrial adenine nucleotide translocase, stimulate
the mitochondrial long-chain acyl-CoA synthetase, and extract
membrane-imbedded acyl-CoA esters and donate them to
utilizing systems such as glycerolipid synthesis and β-oxidation
[12,13]. Furthermore, it has been demonstrated that overexpres-
sion of Acb1p and bovine ACBP in S. cerevisiae increased
the acyl-CoA ester pool size [14,15]. Thus ACBP may act as
an acyl-CoA ester pool former and transporter in vivo. Despite
this, the precise in vivo function of ACBP is currently unknown.
Yeast cells which lack Acb1p activity display a variety of
defects, including fragmented vacuoles, a multi-layered plasma
membrane, accumulation of vesicles of variable sizes, a 3–5.5-
fold elevation in the OLE1 mRNA level, and reduced levels
of very-long-chain fatty acids, ceramides and sphingolipids
[4,16,17]. Owing to the high affinity of ACBP for acyl-CoA
esters and the presence of cytosolic acyl-CoA hydrolases, the
intracellular free acyl-CoA ester concentration is predicted to be
very low [10]. It can therefore be expected that the Acb1p–acyl-
CoA ester complex can modulate processes which are regulated by
acyl-CoA esters and processes which consume acyl-CoA esters,
either directly or indirectly through the donation of acyl-CoA
esters.
In the present study, we used whole genome cDNA micro-
arrays and Q-RT-PCR (quantitative real-time PCR) in order
to identify transcriptional changes in response to the cellular
depletion of Acb1p. Current knowledge suggested that depletion
of Acb1p changes the expression of genes encoding proteins
involved in fatty acid and phospholipid synthesis, glycolysis,
glycerol metabolism, ion transport/uptake and the stress response.
Moreover, the present study has identified an Acb1p-dependent
connection between fatty acid metabolism and transcriptional
regulation of phospholipid biosynthesis in yeast. It also
demonstrated that the regulatory effects of Acb1p depended on
its ability to bind acyl-CoA esters.
EXPERIMENTAL
Chemicals
Bacto peptone, yeast extract and YNB (yeast nitrogen base)
were purchased from Difco (BD Diagnostic Systems). HRP
(horseradish peroxidase)-conjugated goat anti-(mouse IgG) and
goat anti-(rabbit IgG) secondary antibodies were obtained
from Promega. Restriction enzymes and DNA/RNA-modifying
enzymes were either from New England Biolabs or Invitrogen.
All chemicals were of analytical grade.
Yeast strains, media and growth
The S. cerevisiae strains used in the present study are listed
in Table 1. Y700 pGAL-ACB1 is a conditional knockout strain
constructed by insertion of the GAL1 promoter in front of the
ACB1 gene, as described by Gaigg et al. [16]. In the wild-
type strain, Y700, and the Y700 pGAL-ACB1 strain, single
disruptions in SCS2 and PLD1 (SPO14), in which the target ORF
(open reading frame) was disrupted by the TRP1 marker, were
constructed by PCR-mediated gene replacement using pFA6a-
TRP1 as a template (a gift from Professor John R. Pringle,
Department of Biology, The University of North Carolina, Chapel
Hill, NC, U.S.A.) as described previously [18]. Disruption of the
HAC1 gene was achieved by homologous recombination of
the BamHI-linearized pHAKO1 plasmid (a gift from Professor
Peter Walter, Howard Hughes Medical Institute, University of
California, San Francisco, San Francisco, CA, U.S.A.) into
the wild-type strain, Y700, and the Y700 pGAL-ACB1 strain.
Correct integration of TRP1 PCR products and pHAKO1 in
Y700 and Y700 pGAL-ACB1 cells was confirmed by PCR.
Media used to grow yeast included YPD (yeast extract, peptone
and dextrose), YPgal (yeast extract, peptone and galactose) and
YNBD (YNB and dextrose), made as described previously [17],
and glucose-supplemented SC (synthetic complete) medium,
made as described by Sherman [19]. Myo-inositol was either
omitted from SC medium or added to the concentration indicated
as required. Choline was added to a final concentration of
1 mM, and palmitic acid or palmitoleic acid was added to a
final concentration of 500 µM where indicated. Yeast strains
were established on YPgal or YNBgal (YNB and galactose)
medium and cultivated at 30 ◦C. Prior to experimentation, glucose-
supplemented SC, YNBD or YPD medium was inoculated with
yeast cells to a D600 (attenuance) of 0.005–0.01 and grown for
24 h. These cultures were diluted into fresh medium to a D600 of
0.05–0.1 and grown to the required D600. Depletion of Acb1p was
confirmed by Western blotting after each experiment.
Protein extraction, electrophoresis and Western blotting
Protein extraction, electrophoresis and Western blotting was
performed as described in [17], with the exception that PVDF
membranes were used instead of nitrocellulose membranes.
Mouse influenza HA (haemagglutinin) antiserum was obtained
from Roche Diagnostics and used at a 1:5000 dilution.
HRP-conjugated goat anti-(mouse IgG) and goat anti-(rabbit IgG)
secondary antibodies were both used at a concentration of 1:8000.
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DNA microarray
Yeast DNA microarrays were purchased from MWG. A total of
6250 gene-specific oligonucleotide probes (40-mers) representing
the complete S. cerevisiae genome were spotted on to one single
epoxy-coated slide (1.8 cm × 3.6 cm). In addition, each MWG
Yeast Array contained 86 replicated spots and 32 Arabidopsis
control spots.
Yeast culture and total RNA isolation
Wild-type (Y700) and conditional ACB1-knockout (Y700 pGAL-
ACB1) cells were grown to a D600 of 0.9–1.3 in YPD, YNBD or
glucose-supplemented SC medium as described above. Following
growth, cells were collected by centrifugation at 4500 g for 10 min
at 4 ◦C in 50 ml Falcon tubes half-filled with crushed ice. The
supernatant was removed, and cells were transferred to 1.5 ml
microcentrifuge tubes and pelleted by centrifugation at 12800 g
for 3 min at 4 ◦C. Harvested cells were frozen in liquid nitrogen
and stored at −80 ◦C. Total RNA was extracted using the hot
phenol method as described previously [20]. DNase I digestion of
the extracted RNA was performed following the manufacturer’s
instructions (MWG).
cDNA synthesis and post-labelling
RNA was isolated from Y700 and Y700 pGAL-ACB1 cells
grown in YPD medium. For cDNA synthesis and post-labelling,
the CyScribe cDNA post-labelling kit (Amersham Biosciences)
was used. cDNA synthesis and post-labelling was performed as
described by the manufacturer (Amersham Biosciences), except
that amino allyl-modified cDNA was purified using the Qiagen
QIAquick PCR purification kit, in which the supplied wash and
elution buffers were replaced with phosphate wash buffer [5 mM
potassium phosphate buffer, pH 8.0, and 80% (v/v) ethanol]
and phosphate elution buffer (4 mM potassium phosphate buffer,
pH 8.5) respectively to avoid production of free amines.
Hybridization, washing and scanning
For hybridization, a formamide-based hybridization buffer
(MWG) was used. Cy3 (indocarbocyanine)- and Cy5 (indodi-
carbocyanine)-labelled cDNA was pooled, dried, resuspended
in 30 µl of pre-heated (42 ◦C for 10 min) formamide-based
buffer (MWG) and then incubated at 95 ◦C for 3 min. This
hybridization mixture was centrifuged briefly at 10000 g for
15 s at 22 ◦C and applied to the yeast DNA microarray under a
clean coverslip. Slides were then placed into a wet hybridization
chamber (GeneMachines®) and incubated for 18–22 h in a 42 ◦C
water bath. After incubation, the microarrays were washed as
described by the manufacturer (MWG). The arrays were then
dried by centrifugation at 500 g for 2 min at room temperature
(22 ◦C) and scanned at 532 nm (Cy3) and 635 nm (Cy5) in a
GMS-418 scanner (Genetic MicroSystems). Overlay images were
constructed using the microarray spot-finding and quantification
software, ImaGene version 4.2 (BioDiscovery).
Experimental setup and data analysis
RNA isolated from five different cultures of either Y700 or
Y700 pGAL-ACB1 cells grown in YPD medium was pooled in
two different tubes. cDNA synthesized from Y700 and Y700
pGAL-ACB1 RNA was labelled with Cy3 and Cy5 respectively.
The experiment was repeated on independent cultures with
opposite Cy3/Cy5 labelling. Overlay images were processed
using ImaGene version 4.2 software (BioDiscovery). Fluorescent
spots were located, and extracted intensity values were corrected
for local background by subtracting the intensity level around
each spot from the spot’s signal intensity. Intensities corrected
for background were processed and analysed further using
Acuity version 4.0 software (Axon Instruments). Data from each
microarray were normalized using print-tip locally weighted
linear regression (lowess) normalization, and average log2 (R/G)
values (M values) were calculated. In dual-colour experiments,
R and G represent the processed and normalized intensity
values measured using the red and green channel respectively.
Subsequently, data were filtered in order to remove unreliable
data from the dataset. Quality measurements were collected using
ImaGene 4.2 and used to identify low-quality spots. Two quality
parameters were measured for each spot: the number of pixels
that touch the signal area which are neither signal nor background
and all of the ignored and background pixels that fall within the
circle defined by the spot-finding method. Spots defined by this
quality control method to be ‘bad quality’ and data with intensity
levels below the highest intensity level of the 32 Arabidopsis
control spots at 532 nm (Cy3) and 635 nm (Cy5) were removed.
Furthermore, data that were not present in both microarrays
were also excluded. M values were then transferred to Microsoft
Excel and the S.D. was calculated. Data with S.D. > 0.6 were
removed. However, to avoid removing data which represented
genes which were highly up- or down-regulated in both arrays
but had S.D. > 0.6, the list of removed data was checked for
such important data. Finally, genes considered to be differentially
expressed were identified using a fold-change filter, in which the
cut-off was set to an absolute M value of 0.70 (which corresponded
to a 1:1.6 ratio of expression between wild-type and Acb1p-
depleted cells).
Q-RT-PCR, RNA isolation and cDNA synthesis
Total RNA was isolated from cells cultured and harvested as
described above. RNA was extracted using the hot phenol
method as described previously [20] and treated with DNase
I, following the manufacturer’s instructions (MWG). cDNA
was synthesized using Superscript II reverse transcriptase
(Invitrogen) and random hexamers (deoxy-NTP6) (Amersham
Biosciences). Q-RT-PCR was performed on an ABI PRISM 7700
RealTime PCR-machine (Applied Biosystems) using 2×SYBR
Green JumpStartTM Taq ReadyMixTM and Sigma Reference
Dye (Sigma–Aldrich), following the manufacturer’s instructions.
Reactions were incubated at 95 ◦C for 2 min, followed by
40 cycles of 95 ◦C for 15 s, 60 ◦C for 45 s and 72 ◦C for 45 s.
Fluorescence signals were measured during the elongation step,
and all reactions were performed in duplicate. The level of the
target mRNAs was examined and normalized to the level of
the ACT1 gene (actin) using the 2−CT method [21]. Primers
for Q-RT-PCR were designed using Primer Express version
2.0 (Applied Biosystems), and the efficacy and specificity of
the primers was tested by dilution experiments and melting
curves respectively. Used primer sets are listed in Supplementary
Table S1 (http://www.BiochemJ.org/bj/407/bj4070219add.htm).
Primer pairs were designed to amplify a fragment of approx.
50 bp, except for the HAC1 primer pairs which amplified a
fragment of 91 bp.
β-Galactosidase assay in yeast
Y700 and Y700 pGAL-ACB1 cells transformed with plasmid
pJH359 carrying an INO1-CYC1-lacZ fusion (a gift from
Professor Susan Henry, Department of Molecular Biology and
Genetics, Cornell University, Ithaca, NY, U.S.A. [22]) were grown
overnight in an appropriate medium, diluted to a D600 of 0.05–0.1
and grown to a D600 of 0.6–0.8. β-Galactosidase activity in yeast
was determined as described previously [23]. β-Galactosidase
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activity (in units) was calculated according to the following
equation:
Activity = A420/(D600 of assayed culture × volume assayed × time)
where A420 is the absorbance of ONP (o-nitrophenol), D600 is the
attenuance of the culture at the time of assay, volume is the amount
of the culture used in the assay (in ml) and time is measured in
min.
Complementation of INO1 expression by increased fatty acid
synthesis
Increased fatty acid synthesis was achieved by transforming Y700
(wild-type) and the Y700 pGAL-ACB1 strains with high-copy
plasmids expressing either ACC1 (pG1M-ACC1, a gift from
Keiji Furukawa, Kiku-Masamune Sake Brewing Co., Kobe, Japan
[24]) or FAS1 (pJS229, a gift from Professor Hans-Joachim
Schu¨ller, Universita¨t Greifswald, Greifswald, Germany [25]). The
corresponding empty vectors were transformed to be used as
controls. Total RNA was extracted from exponentially growing
cells cultured in selective SC medium supplemented with 0.2 mM
inositol and used for Q-RT-PCR analysis.
Assay for the Opi− (overproduction of inositol) phenotype
To test for the Opi− phenotype, Acb1p-depleted cells and wild-
type cells were dotted on to inositol-free SC plates and grown at
30 ◦C. Plates were then sprayed with a suspension of a diploid
tester strain, AID (provided by Professor Susan Henry), which
is homozygous for ino1 and ade1, and incubated at 30 ◦C as
previously described [26].
LC (liquid chromatograhy)–ESI (electrospray ionization)
MS of lipids
The number of Acb1p-depleted cells at a given D600, is
reduced compared with wild-type cells, implying that Acb1p-
depleted cells are bigger than wild-type cells (S. Feddersen, J.
Knudsen and N. J. Færgeman, unpublished work). Thus whenever
quantifying the relative phospholipid content of Acb1p-depleted
cells compared with wild-type cells, we corrected for differences
in cell numbers. Lipids were extracted from 25 D600 units of
exponentially growing cells (D600 of ∼1) using procedure IIIA as
described by Hanson and Lester [27]. Aliquots corresponding
to 10 D600 units of cells were dissolved in 65 ◦C solvent A
(chloroform/methanol/water, 16:16:5, by vol.) and mixed with
internal standard lipids extracted from 10 D600 units of cells
grown on 13C-glucose as the sole carbon source. The solvent
was evaporated under a stream of nitrogen, and the lipids were
redissolved in 10 µl of solvent A (heated to 65 ◦C) by stirring
using a rotating pestle at 30000 rev./min for 5 min. Immediately
after mixing, 1 µl of the lipid solution was injected on to a
PVA SIL HPLC column (1 mm × 150 mm, YMC Europe) and
eluted at 45 µl/min. Solvents B (hexane/propan-2-ol, 98:2, v/v),
C (chloroform/propan-2-ol, 65:35, v/v) and D (methanol) were
changed linearly over time to give the proportions (by vol.)
of B/C/D at the following time points: 0 min, 100:0:0; 22 min,
12:88:0; 30 min 10:74:16; 45 min, 8:61:31; 50–65 min, 0:0:100;
70–72.5 min, 0:100:0, and 75–82.5 min, 100:0:0. Ions in the
effluent were ionized by ESI with an electrode potential of 3500 V,
and the masses were detected using a Bruker Esquire-LC ion-
trap mass spectrometer. The 12C/13C ratio of ion counts for each
individual 12C species and one selected 13C species in each lipid
class were calculated for both strains. Differences in the relative
amount of individual lipid species between wild-type and Acb1p-
depleted cells were calculated by dividing the wild-type 12C/13C
ratio with the corresponding 12C/13C ratio of Acb1p-depleted cells.
Species percentage composition, based on the sum of ion counts
for all species within a certain lipid class, was calculated for
all lipid classes. The content of a given phospholipid class in
Acb1p-depleted cells was normalized to wild-type levels (wild-
type = 100%) and calculated using the following equation:
Content =
∑
{% individual phospholipid species in
Wt/[(Wt12C/13C)/(12C/13C)]}
where  is Y700 pGAL-ACB1 and wild-type (Wt) is Y700.
RESULTS
Genome-wide changes in gene expression of S. cerevisiae in
response to Acb1p depletion
DNA microarray profiling revealed that the effect of Acb1p
depletion on gene expression is not restricted to OLE1 [4,16]. A
total of 134 genes were identified as being differentially expressed
more than 1.6-fold, of which 44 genes were down-regulated and
90 genes were up-regulated in Acb1p-depleted cells compared
with wild-type cells.
Confirmation of microarray data by Q-RT-PCR
Expression of 22 selected genes, of which ten had been shown
to be differently expressed by microarray analysis, was examined
by Q-RT-PCR (Table 2). The ten genes identified by microarray
analysis were all shown to be differentially expressed to the same
degree by Q-RT-PCR analysis (Table 2). We propose that the
identified changes in gene expression measured by microarray
analysis may reflect actual changes in mRNA levels, in response
to Acb1p depletion. However, in the present study, we primarily
focus on microarray data which have been confirmed by Q-RT-
PCR.
Genes associated with lipid metabolism
The present microarray analysis and Q-RT-PCR analysis show
that genes encoding proteins involved in fatty acid biosynthesis
(ACC1, FAS1, FAS2 and OLE1) all are up-regulated in Acb1p-
depleted cells compared with wild-type cells (Table 2 and
see Supplementary Table S2 at http://www.BiochemJ.org/bj/407/
bj4070219add.htm). Consistent with previous findings, the gene
encoding the yeast 9 desaturase OLE1, was found to be up-
regulated approx. 4-fold in Acb1p-depleted cells cultured in
YNBD medium (results not shown) and approx. 2-fold in cells
cultured in YPD medium (Table 2) [4,16].
The microarray and Q-RT-PCR data also revealed that genes
encoding enzymes involved in phospholipid biosynthesis (INO1,
CHO1, CHO2 and OPI3) are up-regulated in Acb1p-depleted
cells (Table 2). Moreover, the expression of both PSD1 and
PSD2, which also encode phospholipid biosynthesis enzymes,
was increased 1.3-fold in Acb1p-depleted cells compared with
wild-type cells (Table 2), as observed by Q-RT-PCR. This suggests
that synthesis of glycerophospholipids may be affected in cells
depleted of Acb1p. In particular, the INO1 gene encoding the
inositol-3-phosphate synthase (Ino1p) that catalyses synthesis
of inositol-3-phosphate, the rate-limiting and committed step in
the synthesis of PI (phosphatidylinositol), was strongly affected
by Acb1p depletion. Although below the detection level of the
microarrays, INO1 mRNA levels were detected by Q-RT-PCR and
found to be up-regulated approx. 150-fold after Acb1p depletion
(Table 2). INO1 mRNA and Ino1p levels were investigated further
under different growth conditions.
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Table 2 Comparison of fold change (Acb1p depleted cells compared with wild-type cells) obtained by microarray and Q-RT-PCR analysis
Fold change*
Gene ID Gene Function Process Microarray analysis Q-RT-PCR†
Stress response
ygr088w CTT1 Catalase T, cytosolic Response to stress No data‡ 3.1 +− 0.14
ybr072w HSP26 Heat-shock protein Response to stress No data‡ 5.9 +− 1.4
yol052c-a DDR2 Heat-shock protein DDRA2 Response to stress 6.9 +− 0.71 2.7 +− 0.66
yll026w HSP104 Heat-shock protein Response to stress No data‡ 3.1 +− 0.41
yfl014w HSP12 Heat-shock protein Response to stress No data‡ 6.8 +− 1.6
C-compound and carbohydrate metabolism
ydl022w GPD1 Glycerol-3-phosphate dehydrogenase (NAD+), cytoplasmic Intracellular accumulation of glycerol 6.4 +− 1.8 5.5 +− 0.89
yjl052w TDH1 Glyceraldehyde-3-phosphate dehydrogenase 1 Glycolysis; gluconeogenesis 4.8 +− 0.16 3.3 +− 0.91
Lipid metabolism
ygl055w OLE1 Stearoyl-CoA desaturase Fatty acid desaturation 1.9 +− 0.75 1.9 +− 0.45
yjl196c ELO1 Fatty acid elongation protein Fatty acid elongation No data‡ 1.2 +− 0.11
ykl182w FAS1 Fatty-acyl-CoA synthase, β chain Fatty acid biosynthesis 1.6 +− 0.25 1.6 +− 0.41
ypl231w FAS2 Fatty-acyl-CoA synthase, α chain Fatty acid biosynthesis 1.8 +− 0.17 1.6 +− 0.26
yhr007c ERG11 Cytochrome P450 lanosterol 14α-demethylase Ergosterol biosynthesis No data‡ -1.9 +− 0.10
yjl153c INO1 Myo-inositol-3-phosphate synthase PI biosynthesis No data‡ 151 +− 10.7
ygr170w PSD2 Phosphatidylserine decarboxylase 2 PS biosynthesis No data‡ 1.3 +− 0.11
ygr157w CHO2 Phosphatidylethanolamine N-methyltransferase PC biosynthesis 1.8 +− 0.51 1.6 +− 0.02
yjr073c OPI3 Methylene-fatty-acyl-phospholipid synthase PC biosynthesis 2.9 +− 0.68 6.5 +− 0.55
ynl169c PSD1 Phosphatidylserine decarboxylase 1 PS biosynthesis No data‡ 1.3 +− 0.17
ypr113w PIS1 CDP-diacylglycerol–inositol 3-phosphatidyltransferase PI biosynthesis No data‡ 1.1 +− 0.07
yer026c CHO1 CDP-diacylglycerol serine O-phosphatidyltransferase PS biosynthesis 1.8 +− 0.24 1.7 +− 0.14
Others
ypl154c PEP4 Aspartyl protease Vacuolar protein, catabolism 1.8 +− 0.14 1.7 +− 0.32
yor061w CKA2 CK2 α′ chain G2/M and G1/S transition etc. No data‡ −1.2 +− 0.12
yfl031w HAC1 Transcription factor Unfolded protein response No data‡ 5.6 +− 0.39
ylr350w ORM2 Strong similarity to ORM1 Response to unfolded protein 2.8 +− 0.43 Not determined
ycl043c PDI1 Protein disulfide-isomerase precursor Protein folding 2.2 +− 0.17 Not determined
yjl034w KAR2 Nuclear fusion protein Response to unfolded protein 1.9 +− 0.98 Not determined
* Positive values represent fold up-regulation in Acb1p-depleted cells compared with wild-type cells, whereas negative values represent fold down-regulation in Acb1p-depleted cells compared with wild-type cells. Data are means +− S.D. Q-RT-PCR, n3;
microarray analysis, n = 2.
† For each Q-RT-PCR analysis, RNA from three or four different cell cultures were used for cDNA synthesis and mean values were calculated. ACT1 was used as endogenous reference.
‡Data are not given because value for intensities were below that of Arabidopsis controls or because data were not present in both (dye-reversal) arrays.
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Figure 1 INO1 mRNA and protein levels during different growth conditions in Acb1p-depleted cells
Q-RT-PCR analysis of INO1 mRNA levels in wild-type (Y700, black bars) and pGAL-ACB1 (Acb1p-depleted Y700, white bars) cells grown in minimal medium (SC) supplemented with choline and/or
inositol as indicated (A) or in rich medium (YPD) (C). Immunoblot analysis of protein extracts from S. cerevisiae containing Ino1p–HA. Wild-type (Y700 Ino1p–HA) and pGAL-ACB1 (Acb1p-depleted
Y700 Ino1p–HA) cells were grown in SC medium supplemented with choline and/or inositol as indicated (B) or in YPD medium (D). The blots in (B) and (D) were re-probed with rabbit anti-Vac8p
antibody (a gift from Professor Lois S. Weisman, Life Sciences Institute and Department of Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI, U.S.A) (1:2000 dilution) to
serve as loading control. Data in (A) and (C) are means +− S.D. (n = 3) and Western blots are representative of three independent experiments.
Regulation of INO1 expression in Acb1p-depleted cells
Most of the genes involved in phospholipid synthesis, e.g.
INO1, OPI3, PIS1, CHO1 and CHO2, are characterized by the
presence of a cis-acting UASINO1 (inositol-sensitive upstream
activating sequence), also called an ICRE (inositol/choline-
responsive element), in their promoters (for a review see [28]).
Transcription of UASINO1-containing genes is positively regulated
by Ino2p and Ino4p, which bind to UASINO1 elements and activate
transcription when cells are grown in the absence of inositol and
choline. Repression occurs in the presence of high concentrations
of inositol and choline and is mediated by Opi1p, which acts
as a negative regulator (for a review see [29]). In the absence of
inositol and choline, Opi1p is sequestered in the ER (endoplasmic
reticulum) membrane by binding to PA (phosphatidic acid) and
Scs2p [30]. On addition of inositol and choline, PA is quickly
consumed for the synthesis of PI and PC (phosphatidylcholine),
followed by translocation of Opi1p to the nucleus [30] where it
represses UASINO1-dependent expression indirectly, presumably
by interacting with the Ino2p transcriptional activator.
INO1 mRNA and the corresponding Ino1p protein level were
both found to be significantly up-regulated in Acb1p-depleted
cells in comparison with wild-type cells, when grown in both YPD
and SC medium supplemented with 0.2 mM inositol (Figure 1).
This suggests that full repression of INO1 mRNA and Ino1p by
inositol requires the presence of Acb1p. Consistent with this,
we did not observe a significant difference in UASINO1-driven
β-galactosidase activity between wild-type and Acb1p-depleted
cells when cultured in inositol-free medium (results not shown).
In contrast, when grown in YNBD medium supplemented with
Figure 2 UASINO1-driven gene expression is increased in Acb1p-depleted
cells
Wild-type (Y700, black bars) and pGAL-ACB1 (Acb1p-depleted Y700, white bars) cells were
grown in YNBD medium (without inositol) or supplemented with inositol as indicated. Cells were
transformed with the INO1-CYC1-lacZ plasmid and β-galactosidase activity was measured to
assess the ability of UASINO1 elements to drive lacZ expression in wild-type and Acb1p-depleted
cells. β-Galactosidase activity was defined as described in the Experimental section. Data are
means +− S.D. (n = 3).
either 0.02 mM inositol or 0.2 mM inositol, UASINO1-driven β-
galactosidase expression was approx. 3-fold higher in Acb1p-
depleted cells compared with wild-type cells (Figure 2). Up-
regulation of INO1 transcription in Acb1p-depleted cells may
be caused by increased UASINO1-driven transcription as a result of
reduced inositol-mediated repression. This notion is supported
by the fact that other genes containing UASINO1 elements in
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their promoter, including OPI3, CHO1 and CHO2, are also
up-regulated in Acb1p-depleted cells (Table 2). In a recent
microarray study, a total of 36 Ino2p and Ino4p target genes were
identified [31]. On Acb1p depletion, 20 of these genes were found
to be up-regulated (at least 1.5-fold), three were down-regulated
(at least 1.5-fold), and 13 genes were not shown to be differently
expressed when compared with wild-type cells. This indicates
that inositol-mediated repression of Ino2p and Ino4p target genes
at steady-state depends on Acb1p. Since Ino2p, Ino4p and Opi1p
regulate transcription of UASINO1-containing genes, mRNA levels
of these transcription factors were measured by Q-RT-PCR. We
found that the mRNA level of INO2 and INO4 were increased
approx. 2-fold in Acb1p-depleted cells on comparison with wild-
type cells grown in rich medium, whereas no significant changes
was observed for cells grown in minimal medium (results not
shown). The mRNA level of OPI1 was increased approx. 1.3-
fold in Acb1p-depleted cells compared with wild-type cells when
grown in rich medium, whereas the mRNA level was decreased
approx. 1.3-fold when cells were grown in minimal medium
(results not shown).
Acb1p depletion reduces inositol-mediated repression of INO1 by
an Opi1p-independent regulatory mechanism
Since INO1, CHO1, CHO2 and OPI3 were identified to be
up-regulated in Acb1p-depleted cells, we speculate that the
transcriptional repressor Opi1p is sequestered in the ER mem-
brane of these cells, as a result of higher levels of PA and/or
Scs2p. Disruption of SCS2 reduced INO1 expression in both
wild-type and Acb1p-depleted cells, but INO1 mRNA levels
were still increased approx. 60-fold (Figure 3A) and approx.
5.5-fold (Figure 3B) in Acb1p-depleted cells grown in YPD
medium or SC medium containing 0.2 mM inositol respectively.
A similar expression pattern was observed for OPI3 on disruption
of SCS2 (results not shown). Moreover, SCS2 mRNA levels were
unaffected by Acb1p depletion (results not shown), and relative
PA levels were unchanged or lower in Acb1p-depleted cells
compared with wild-type cells (Table 3). Finally, overexpression
of OPI1 did not reduce INO1 mRNA levels of Acb1p-depleted
cells to that of wild-type cells (results not shown). Taken together,
these observations suggest that Acb1p depletion reduces inositol-
mediated repression of INO1 and other Ino2p and Ino4p target
genes by an Opi1p-independent regulatory mechanism.
Acb1p-depleted S. cerevisiae exhibit an Opi− phenotype, but do
not accumulate PA
The Opi− phenotype has previously been associated with de-
regulation of the INO1 gene [32]. Therefore we tested Acb1p-
depleted cells for an Opi− phenotype [32]. Growth of an
inositol-dependent strain around Acb1p-depleted cells grown
on synthetic inositol-free plates, shows that Acb1p depletion
leads to inositol secretion (Figure 4A). Moreover, it has been
shown that strains carrying deletions in CHO1, CHO2 or
OPI3 have defects in PC synthesis, are unable to repress
INO1 in the presence of inositol and exhibit a conditional
Opi− phenotype, owing to the accumulation of PA [32,33].
Expression of INO1 and the Opi− phenotype can be normalized
in these strains by the addition of exogenous choline, which
alleviates PA accumulation by increasing PC synthesis via the
CDP (cytidyldiphosphate)–choline pathway [28,34]. Thus if
accumulation of PA causes increased INO1 expression in Acb1p-
depleted cells, supplementation of both choline and inositol
would be expected to repress INO1 mRNA and Ino1p levels
further in both wild-type and Acb1p-depleted cells, compared
with addition of inositol alone. However, addition of choline to
Figure 3 INO1 mRNA levels in wild-type and Acb1p-depleted cells with
SCS2, PLD1 or HAC1 disrupted
Q-RT-PCR analysis of INO1 mRNA levels in wild-type (Y700) and pGAL-ACB1 (Acb1p-depleted
Y700) cells disrupted in SCS2, PLD1 or HAC1 genes, following growth in rich (YPD) medium
(A) or minimal (SC) medium supplemented with 0.2 mM inositol (B). Data are means +− S.D.
(n = 3).
inositol-containing medium resulted in only a minor decrease in
INO1 mRNA and Ino1p levels in Acb1p-depleted cells compared
with wild-type cells (Figures 1A and 1B). Hence increased INO1
expression in Acb1p-depleted cells may not be caused by the ac-
cumulation of PA as a result of reduced PC synthesis by the
PE (phosphatidylethanolamine) methylation pathway. Increased
phospholipase D1 (Pld1p)-mediated turnover of PC has also
been reported to result in derepression of the INO1 gene [26]
probably by accumulation of PA. However, in a pld1-null
background, INO1 levels were still increased approx. 90-fold
(Figure 3A) and approx. 4.5-fold (Figure 3B) in Acb1p-depleted
cells grown in YPD medium and SC medium containing 0.2 mM
inositol respectively. Increased PC turnover does not seem to
cause derepression of INO1 in Acb1p-depleted cells. This is in
agreement with our previous data, which showed that PC turnover
is only slightly reduced in Acb1p-depleted cells, compared with
wild-type cells [16]. No increase was found in the relative levels
of PC and PA in Acb1p-depleted cells when compared with
wild-type cells (Table 3). Taken together, these results indicate
that changes in PC metabolism or accumulation of PA are not
responsible for increasing INO1 mRNA and Ino1p levels in cells
depleted of Acb1p.
The mechanism causing induction of INO1 in Acb1p-depleted cells
is independent of HAC1 expression
Eukaryotic cells respond to the accumulation of unfolded proteins
in the ER by activating a stress-response pathway known as
c© The Authors Journal compilation c© 2007 Biochemical Society
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Table 3 The relative phospholipid content of Y700 pGAL-ACB1 cells compared with Y700 cells
The content of a given phospholipid class in Acb1p-depleted cells (Y700 pGAL-ACB1) was normalized to wild-type (Y700) levels (wild-type = 100 %) and calculated using the following equation:
Content =  {% individual phospholipid species in Wt/[(Wt 12C/13C)/( 12C/13C)]}, where  is Y700 pGAL-ACB1 and wild-type (Wt) is Y700. Data are means +− S.D. (n = 2).
Phospholipid content (%)
Medium PA PI PG PS PE PC
YPD 95 +− 7.8 128 +− 15.2 89 +− 18.9 78 +− 2.5 129 +− 7.8 98 +− 15.5
SC medium + 0.2 mM inositol 81 +− 6.8 80 +− 4.4 46 +− 7.6 72 +− 20.8 80 +− 19.1 96 +− 18.1
SC medium without inositol 120 +− 22.5 223 +− 0.9 66 +− 8.4 125 +− 18.9 139 +− 23.5 100 +− 15.9
Figure 4 Acb1p-depleted cells exhibits an Opi− phenotype
(A) Wild-type (Y700) and pGAL-ACB1 (Acb1p-depleted Y700) cells were tested for their ability
to secrete inositol to the surrounding medium when supplemented with or without 0.5 mM
palmitic acid. (B) Q-RT-PCR analysis of INO1 mRNA levels in wild-type (Y700, black bars) and
pGAL-ACB1 (Acb1p-depleted Y700, white bars) cells grown in YNBD medium (without inositol)
supplemented with or without 0.05 % (v/v) Brij58 and 0.5 mM palmitic acid as indicated.
(C) Immunoblot analysis of protein extracts from S. cerevisiae expressing Ino1p–HA. Wild-type
(Y700 Ino1p–HA) and pGAL-ACB1 (Acb1p-depleted Y700 Ino1p–HA) cells were grown in
YNBD medium (without inositol) supplemented with or without 0.05 % (v/v) Brij 58 detergent
and 0.5 mM palmitic acid as indicated. The blot was re-probed with an antibody against Vac8p
to serve as a loading control. Data in (B) are means +− S.D. (n = 3) and the Western blot is
representative of three independent experiments.
the UPR (unfolded protein response) pathway (for a review
see [35]). In S. cerevisiae, the UPR pathway may also be
activated in response to inositol starvation and it is coupled to
inositol biosynthesis, as cells defective in UPR activation require
exogenous inositol for growth and express low levels of INO1
[36]. In yeast, it has been proposed that Hac1p negatively regulates
the activity of Opi1p [37]. Interestingly, HAC1, PDI1, KAR2 and
ORM2 were identified in the present study as being up-regulated
in cells depleted of Acb1p (Table 2), which is indicative of
induction of the UPR pathway. Disruption of HAC1 diminished
INO1 mRNA levels in wild-type cells and cells depleted of Acb1p
(Figure 3). However, INO1 mRNA levels were still increased
approx. 40-fold (Figure 3A) and approx. 5-fold (Figure 3B) in
Acb1p-depleted cells compared with wild-type cells when grown
in YPD and SC medium containing 0.2 mM inositol respectively.
These results clearly demonstrate that the observed reduction in
inositol-mediated repression of INO1 in cells lacking Acb1p is not
the result of induction of the UPR pathway. This suggestion is
supported by a recent microarray study which showed that Opi1p-
mediated repression of INO1 in response to inositol cannot be
prevented by constitutive activation of the UPR pathway [31].
Phospholipid analysis by LC–ESI MS/MS
To examine whether the observed induction of genes encoding
enzymes involved in phospholipid biosynthesis in Acb1p-
depleted cells is caused by changes in the overall phospholipid
content, we measured the relative levels of PC, PI, PE, PG
(phosphatidylglycerol), PS (phosphatidylserine) and PA using
LC–ESI–MS/MS, with 13C-labelled yeast lipids used as internal
standards. Acb1p-depleted cells grown in YPD medium, exhibited
an approx. 30% increase in the relative level of the major
glycerolphospholipids, PI and PE, and unchanged levels of
PC, PG and PA compared with wild-type cells (Table 3).
However, the relative level of PS was decreased by approx.
20% in the Acb1p-depleted cells. For Acb1p-depleted cells
grown in SC medium supplemented with 0.2 mM inositol, it
was found that the relative levels of PA, PI, PS and PE was
reduced by approx. 20%, whereas the PC level was unchanged
compared with wild-type cells. In contrast, the relative PG
level was decreased by approx. 50% (Table 3). These results
indicate that a reduction in the relative phospholipid content
is not solely responsible for the induction of phospholipid
biosynthesis genes in Acb1p-depleted cells, since only the
relative PS level was consistently reduced under all conditions.
Therefore Acb1p may act downstream or independently of
the signal produced through phospholipid metabolism to affect
INO1 expression. However, it should be noted that the relative
phospholipid species composition is altered in Acb1p-depleted
cells compared with wild-type cells (see Supplementary Tables
S3–S8 at http://www.BiochemJ.org/bj/407/bj4070219add.htm).
Acb1p depletion causes a shift from C34:1 species towards C34:2
and C32:1 or C32:2 species in the PI, PG, PS and PA classes,
independently of whether cells are grown in YPD medium or SC
medium supplemented with 0.2 mM inositol (see Supplementary
Tables S3–S8). These results confirm that Acb1p depletion leads
to changes in the relative species composition of phospholipids, as
reported previously [17]. Thus it cannot be excluded that changes
in the relative species composition of phospholipids in Acb1p-
depleted cells results in the observed alteration in expression of
genes encoding enzymes involved in phospholipid biosynthesis.
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Figure 5 Fatty acid supplementation normalizes INO1 and OPI3 expression
on Acb1p depletion
Q-RT-PCR analysis of INO1 (A) and OPI3 (B) mRNA levels in wild-type (Y700, black bars)
and pGAL-ACB1 (Acb1p-depleted Y700, white bars) cells is shown. Cells were grown in rich
medium (YPD) containing 0.05 % (v/v) Brij 58 detergent in the presence or absence of 0.5 mM
palmitic acid (C16:0) or 0.5 mM palmitoleic acid (C16:1) as indicated. Data are means +− S.D.
(n = 3).
Supplementation with fatty acids or overexpression of FAS1 or
ACC1 can normalize inositol-mediated repression of INO1 in
Acb1p-depleted cells
A link between fatty acid metabolism and INO1 expression has
previously been reported by Shirra et al. [38], who found that
inhibition of acetyl-CoA carboxylase (Acc1p) activity restored
expression of INO1 in SNF1 disrupted cells. Moreover, it was
shown that supplementation with palmitoleic acid (C16:1) relieved
inositol auxotrophy and permitted INO1 expression in cells
lacking SNF1 [38]. In addition, Gaspar et al. [39] suggested that
the observed burst in PI synthesis following the addition of inositol
depends on de novo fatty acid synthesis, further indicating a link
between fatty acid biosynthesis and regulation of phospholipid
biosynthesis. Addition of palmitic acid (C16:0) to inositol-
containing medium normalized INO1 and OPI3 expression in
Acb1p-depleted cells to that of wild-type cells (Figure 5). In
contrast, palmitoleic acid only partly normalized INO1 and OPI3
expression in Acb1p-depleted cells to levels observed in wild-
type cells (Figure 5). Notably, palmitoleic acid increased INO1
and OPI3 expression in wild-type cells (Figure 5). This shows
that palmitic acid and palmitoleic acid affect inositol-mediated
repression of Ino2p and Ino4p target genes differently in both
wild-type and Acb1p-depleted cells. However, a signal generated
from fatty acid metabolism may be involved in the regulation
of inositol-mediated repression of Ino2p and Ino4p target genes.
Wenz et al. [25] showed previously that FAS1, but not FAS2,
increased FAS activity 2.8-fold when expressed from a high-
copy plasmid. We therefore hypothesized that ectopic expression
from a high-copy plasmid of FAS1 and ACC1, the rate-limiting
enzyme in fatty acid biosynthesis, would increase fatty acid/acyl-
Figure 6 Ectopic overexpression of ACC1 and FAS1 decreases INO1
expression in Acb1p-depleted cells
(A) Q-RT-PCR analysis of INO1 mRNA levels in wild-type (Y700, black bars) and pGAL-ACB1
(Acb1p-depleted Y700, white bars) cells transformed in pairs with combinations of empty
vectors or construct to be expressed as indicated. Transformants were grown in selective
medium (SC −uracil − tryptophan +0.2 mM inositol). (B) Q-RT-PCR analysis of INO1 mRNA
levels in wild-type (Y700, black bars) and pGAL-ACB1 (Acb1p-depleted Y700, white bars) cells
transformed with either empty vector or construct to be expressed as indicated. Transformants
were grown in selective medium (SC − tryptophan +0.2 mM inositol). Data are means +− S.D.
(n = 3).
CoA ester availability and thereby reduce INO1 expression in
Acb1p-depleted cells. Overexpression of FAS1 reduced the ratio
of INO1 mRNA levels in wild-type cells and Acb1p-depleted
cells from approx. 1:6.5 to approx. 1:2.6 (Figure 6A). No further
effect on INO1 expression was observed when FAS1 and ACC1
were overexpressed at the same time (Figure 6A). Notably, when
ACC1 was overexpressed in cells transformed with the empty
FAS1 vector, the ratio of INO1 mRNA levels in wild-type cells
and Acb1p-depleted cells was only reduced from approx. 1:6.5
to approx. 1:4.7 (Figure 6A). However, ectopic expression of
ACC1 from a high-copy plasmid in cells only transformed with
this plasmid reduced the ratio of INO1 mRNA levels in wild-type
cells and Acb1p-depleted cells from approx. 1:7.4 to approx. 1:2.2
(Figure 6B). A possible explanation for this observation is that
transformation with two plasmids might perturb the copy number
of each one, and therefore the level of expression of individual
proteins may be affected. INO1 mRNA levels could not be reduced
in Acb1p-depleted cells when FAS2 was overexpressed, further
supporting the hypothesis that the observed effects are caused by
an increased availability of fatty acids/acyl-CoA esters (results not
shown). Together, these results show that increased availability of
fatty acids/acyl-CoA esters in Acb1p-depleted cells normalizes
the expression of genes involved in phospholipid biosynthesis.
Thus Acb1p might facilitate removal of de novo synthesized
acyl-CoA esters from the yeast FAS under normal physiological
conditions, thereby making them available for further metabolism
and regulatory processes.
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Figure 7 Acb1p affects gene expression in an acyl-CoA ester-dependent
manner
Q-RT-PCR analysis of INO1 mRNA levels in wild-type (Y700), pGAL-ACB1 (Acb1p-depleted
Y700), pGAL-ACB1 + ACB1 (Acb1p-depleted Y700 complemented with ACB1) and
pGAL-ACB1 + ACB1Y28F/K32A (Acb1p-depleted Y700 complemented with mutant acb1) cells
cultured in SC medium supplemented with 0.2 mM inositol. Data are means +− S.D. (n = 3).
Interestingly, the addition of 500 µM palmitic acid to inositol-
free plates repressed the Opi− phenotype (Figure 4A), in
accordance with the observed effect of palmitic acid on inositol
uptake [16] and membrane abnormalities (S. Feddersen, J.
Knudsen and N. J. Færgeman, unpublished work) in Acb1p-
depleted cells. However, palmitic acid was unable to reduce the
high INO1 mRNA and Ino1p levels of both wild-type and Acb1p-
depleted cells cultured in inositol-free medium (Figures 4B and
4C). This implies that high INO1 expression is not necessarily
associated with the Opi− phenotype.
The in vivo function of Acb1p depends on ligand binding
Depletion of Acb1p in yeast results in slow growth and aberrant
organelle morphology, including fragmented vacuoles, multi-
layered plasma membranes and the accumulation of vesicles of
variable sizes [16,17]. Ectopic expression of Acb1p in Acb1p-
depleted cells normalizes vacuole morphology (S. Feddersen,
J. Knudsen and N. J. Færgeman, unpublished work) and INO1
mRNA levels (Figure 7), whereas expression of Acb1pY28F/K32A,
which exhibited a 1000-fold reduced affinity for acyl-CoA esters
compared with wild-type Acb1p [40], was unable to restore INO1
mRNA levels (Figure 7) and vacuole morphology (S. Feddersen,
J. Knudsen and N. J. Færgeman, unpublished work). The minor
effect of Acb1pY28F/K32A on INO1 expression in Acb1p-depleted
cells is likely to be a result of the protein being overexpressed
and binding acyl-CoA esters with very low affinity. Ectopic
expression of rat L-FABP, which binds acyl-CoA esters with a Kd
of 14–1000 nM [41,42] in Acb1p-depleted cells was also unable
to normalize the INO1 mRNA level (results not shown). This
demonstrates that the function of Acb1p is closely linked to its
ability to bind acyl-CoA esters with high affinity and supports the
hypothesis of Acb1p playing a role in acyl-CoA trafficking.
DISCUSSION
In the present study, we have identified transcriptional changes
in response to Acb1p depletion in genes encoding proteins which
are involved in fatty acid and phospholipid synthesis, glycolysis,
stress response, glycerol metabolism and ion transport and uptake
(Table 2 and Supplementary Table S2). Depletion of Acb1p was
shown to increase transcription of INO1, CHO1, CHO2 and
OPI3, all of which encode proteins required for phospholipid
biosynthesis. A common feature of all of these genes is the
presence of UASINO1 elements in their promoter regions (for a
review see [28]). Regulation via UASINO1 elements involves the
transcriptional activators Ino2p and Ino4p, and the transcriptional
repressor Opi1p [30]. Nuclear localization of Opi1p is regulated
by PA and Scs2p, which bind and detain Opi1p to the ER
membrane. We show that the observed reduction in inositol-
mediated repression of UASINO1-driven transcription in Acb1p-
depleted cells is not caused by altered OPI1 levels or changes in PA
and SCS2 levels. Moreover, INO2 and INO4 mRNA levels were
not significantly altered in Acb1p-depleted cells grown in minimal
medium compared with wild-type cells (results not shown). The
approx. 3-fold increase observed in INO1 mRNA levels of Acb1p-
depleted cells grown in minimal medium (Figure 3B) therefore
may not be caused by increased levels of these transcriptional
activators. Furthermore, Ino2p and Ino4p bind constitutively to
the INO1 promoter, and it has been suggested that occupancy
of the INO1 promoter by Ino2p and/or Ino4p is insufficient
for its activation [37]. Taken together, these results strongly
suggest that the reduction in inositol-mediated repression of
Ino2p and Ino4p target genes in Acb1p-depleted cells occurs by
an Ino2p, Ino4p and Opi1p-independent mechanism. However,
it cannot be excluded that the Acb1p–acyl-CoA ester complex
regulates the activity of Ino2p, Ino4p and Opi1p, either directly
or indirectly. A possible regulatory mechanism is that Acb1p
depletion alters Opi1p phosphorylation, which has been shown to
affect its regulator activity [43].
Activation of the UPR pathway has previously been linked
to increased phospholipid biosynthesis in yeast [37]. However,
we did not find any connection between induction of the UPR
pathway and increased expression of Ino2p and Ino4p target genes
in Acb1p-depleted cells. Moreover, HAC1 disruption reduced the
expression of OPI3 approx. 2-fold in Acb1p-depleted cells grown
in YPD medium, whereas OPI3 expression in wild-type cells was
unaffected by HAC1 disruption (results not shown). The absence
of an effect of HAC1 disruption on OPI3 expression in wild-type
cells confirms that the UPR pathway does not seem to be directly
involved in transcriptional regulation of Ino2p and Ino4p target
genes, as was recently suggested [31].
A large body of evidence suggests that Acb1p functions as an
acyl-CoA ester transporter and pool former. We investigated the
possibility that the altered expression of genes encoding enzymes
involved in phospholipid synthesis, including INO1, in Acb1p-
depleted yeast is the result of an absence of fatty acid metabolites.
Supplementation of exogenous palmitic acid to Acb1p-depleted
cells normalized INO1 and OPI3 mRNA levels to those of wild-
type cells (Figure 5), in contrast with palmitoleic acid, which was
found to partially normalize INO1 and OPI3 levels in Acb1p-
depleted cells compared with wild-type cells (Figure 5). The
difference in the effect of palmitic acid and palmitoleic acid may
be a result of palmitic acid having additional effects on Acb1p-
depleted cells.
Supplementation of palmitic acid to Acb1p-depleted cells
partly restores inositol uptake [16] and reduced inositol secretion
(Figure 4A). This may suggest that the reduction in inositol-
mediated repression of Ino2p and Ino4p target genes, including
INO1, in Acb1p-depleted cells, is simply a cellular response to low
intracellular inositol levels. However, this is not likely to be the
case since Acb1p-depleted cells, although unable to completely
normalize INO1 levels on addition of inositol, do respond to
exogenous inositol by repressing INO1 transcription (Figure 1A).
Disruption of SCS2, which has previously been shown to reduce
INO1 expression in response to inositol depletion [44], did not
normalize INO1 expression in Acb1p-depleted cells (Figure 3).
This further supports the hypothesis that INO1 deregulation in
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Acb1p-depleted cells is caused by means other than a lack of
inositol. The steady-state expression of GPD1 and TDH1, which
is only slightly affected by inositol [45], is dramatically increased
in Acb1p-depleted cells (Table 2), suggesting that at least part
of the transcriptional response accompanying Acb1p depletion is
inositol-independent.
Overall, the above observations present the possibility that
reduced inositol-mediated repression of Ino2p and Ino4p target
genes in Acb1p-depleted cells is the result of decreased
availability of fatty acids and/or acyl-CoA esters. This is strongly
supported by the result that ectopic overexpression of FAS1 and
ACC1 reduced ratios of INO1 mRNA levels in wild-type cells
and Acb1p-depleted cells from approx. 1:6.5 and 1:7.4 to approx.
1:2.6 and 1:2.2 respectively (Figure 6). Notably, overexpression
in Acb1p-depleted cells of FAS2, which is unable to enhance
FAS activity [25], did not reduce INO1 mRNA levels (results
not shown). This suggests that the Acb1p-mediated removal
of de novo synthesized acyl-CoA esters from the yeast FAS
[16] can be overcome by increasing the availability of fatty
acids and/or acyl-CoA esters though enhancement of de novo
fatty acid biosynthesis or supplementation with fatty acids (Fig-
ures 5 and 6). These results strongly support the hypothesis that the
altered availability of fatty acids and/or fatty acid derivatives may
be involved in the mechanism by which Acb1p depletion alters
inositol-mediated repression of Ino2p and Ino4p target genes.
In addition to affecting the expression of phospholipid bio-
synthesis genes, Acb1p depletion also increased the expression
of fatty acid synthetic genes, including ACC1, FAS1, FAS2 and
OLE1 (Table 2 and Supplementary Table S2). This indicates that
the expression of these genes is also regulated by the availability
of specific acyl-CoA esters, made available by Acb1p–acyl-CoA
ester complexes. We have shown previously that depletion of
Acb1p in the temperature-sensitive mutant of ACC1, mtr7-1,
results in lethality at the permissive temperature [16], supporting
the notion that Acb1p affects the availability of acyl-CoA esters.
The acyl species composition of phospholipids is altered on
Acb1p depletion (Supplementary Tables S3–S8). Thus it cannot
be ruled out that these alterations can affect the expression of
Ino2p and Ino4p target genes. One possible model, consistent
with our results, is that Acb1p recruits LCACoA esters to
phospholipid-remodelling enzymes, thereby affecting the acyl
species composition of phospholipids, which then affects the
expression of Ino2p and Ino4p target genes.
Several studies have shown that fatty acids and fatty acid
derivatives affect gene expression directly in both prokaryotes
and eukaryotes [46,47]. A number of these studies suggest that
the active species is acyl-CoA ester. In Escherichia coli, fatty
acid synthesis and degradation is transcriptionally co-ordinated
by the acyl-CoA ester-regulated transcription factor, FadR (for
a review see [46]). Eukaryotic PPARs (peroxisome-proliferator-
activated receptors) are activated by fatty acids and induce
transcription of multiple genes involved in lipid metabolism [47],
whereas LCACoA esters have been reported to antagonize this
effect [48]. Immunogold EM (electron microscopy) has shown
that ACBP/Acb1p is found in the nucleus of a number of
mammalian [49,50] and yeast cells (S. Feddersen, J. Knudsen
and N. J. Færgeman, unpublished work). The Acb1p–acyl-CoA
complex may therefore modulate gene expression by donating
acyl-CoA esters to gene regulatory components in the nucleus.
Such a transport function is compatible with the recent suggestion
implying that ACBP and HNF-4α (hepatocyte nuclear factor 4α)
interact, and ACBP stimulates HNF-4α-mediated transactivation
of HNF-4α target genes in hepatocytes [50].
In conclusion, we suggest that fatty acid derivatives are involved
in the regulation of Ino2p and Ino4p target genes and that increased
expression of these target genes in Acb1p-depleted cells is caused
by a decrease in the availability of acyl-CoA esters, as a result of
the absence of Acb1p.
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